Market research
MBI-H.V Med BioGene Inc
V CAD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 431K
- P/E ratio
- 0.0
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.54
Community
Investor discussion
1 comment
Sign in to join the MBI-H.V discussion.
5 years, 5 months ago
Med BioGene Inc is currently in a long term uptrend where the price is trading 95.5% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Med BioGene Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 177.0% to $-9K since the same quarter in the previous year.
Finally, its free cash flow grew by 779.3% to $83K since the same quarter in the previous year.
Based on the above factors, Med BioGene Inc gets an overall score of 3/5.